Skip to content
Home/Companies/MedTech/Acoesis

Acoesis

MedTech·Italy·Exited 2022·Held 3yr
Entry
2019
Hold
3yr
Exit
2022

Who owns Acoesis?

Acoesis was owned by LigurCapital through Fondo Strategico DGR 30/2019 (2019 vintage) from 2019 to 2022.

Hand-verified · updated 2026-08-01

LigurCapital
Investor
LigurCapital
Fondo Strategico DGR 30/2019 · 2019 · VC

Key facts

HQItaly
SectorMedTech
StatusAcquired
Exit Type
–
Buyer
–
MOIC
–
Exit Year
2022

More from Fondo Strategico DGR 30/2019

Other portfolio companies in the same fund.

Refi
Active
Business ServicesItaly· 2023
Fralur
Active
FoodTechItaly· 2022
BESD
BESD
Exited 2024
ConstructionItaly· 2021
Chite
Exited 2024
E-commerceItaly· 2021
Do Eat Better
Do Eat Better
Exited 2024
E-commerceItaly· 2021
Endless
Exited 2024
ConsumerItaly· 2021

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Optos
Exited 2015
Amadeus Capital PartnersUK
to
Axomove
Axomove
Active
Go CapitalFrance· 2026
Bioliberty
Active
Scottish National Investment BankUK· 2026
CertHub
Active
Cusp Capital PartnersGermany· 2026
Clee Medical
Clee Medical
Active
High-Tech Gruenderfonds (HTGF)Switzerland· 2026
CollimateHealth
Active
Caesar Ventures ManagementGermany· 2026
Track Acoesis

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Acoesis.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue